About Symbiotec Pharmalab
Symbiotec Pharmalab is an established Indian enterprise operating across domestic and global markets. The company is raising capital through this public issue for expansion, working capital, and strategic growth.
Ratio: 1 in 1.6 Applicants (Retail Demand: 1.59x)
Mathematical estimation based on lottery draw allocation rules.📊 Live Bidding Subscription Multiples
Total: 1.77xReal-time demand subscription multiples across Qualified Institutional, HNI, and Retail investor quotas.
Financial Summary (in ₹ Crore)
| Financial Metric | Latest Value (₹ Cr) | Health Indicator |
|---|---|---|
| Total Revenue | ₹88.92 Cr | Profitable |
| Profit After Tax (PAT) | ₹10.67 Cr | Positive Margin |
| Net Worth | ₹57.8 Cr | Adequate Capital |
❓ Frequently Asked Questions about Symbiotec Pharmalab
What is the lot size for Symbiotec Pharmalab IPO?
The minimum market lot for Symbiotec Pharmalab IPO is 15 shares, requiring a minimum retail application of approximately ₹14,820.
What is the current Grey Market Premium (GMP) of Symbiotec Pharmalab IPO?
As per current market updates, the Grey Market Premium (GMP) of Symbiotec Pharmalab IPO is ₹388 per share, indicating an estimated listing price of ₹1376 (39.3% listing gain).
Who is the official registrar for Symbiotec Pharmalab IPO?
KFintech is the official registrar for Symbiotec Pharmalab IPO. You can check your allotment status directly on their online portal.